Sabine Tejpar

Researcher Next ID · RN-007716

Researcher · Medicine

Leuven, Belgium

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Colorectal Cancer Treatments and Studies

Genetic factors in colorectal cancer

Cancer Genomics and Diagnostics

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Annals of Oncology · 2016 · https://doi.org/10.1093/annonc/mdw235
The consensus molecular subtypes of colorectal cancer
Nature Medicine · 2015 · https://doi.org/10.1038/nm.3967
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70130-3
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0805019
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.3452

No projects listed.